A/Prof Pearly Khaw
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
28 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
POLARIX: POLE-mutation analysis by rapid image-based screening in endometrial cancer
DOI: 10.1016/j.ijgc.2025.1044362025
Journal article
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
DOI: 10.1016/S1470-2045(25)00379-12025
Conference Proceedings
1172P The relationship between patient-reported outcomes and clinician-rated toxicity in participants with locally advanced cervix cancer in the OUTBACK trial
DOI: 10.1016/j.annonc.2025.08.18082025
Journal article
Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological Correlates
DOI: 10.1016/j.modpat.2024.1006602024
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases
2024
Journal article
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup
DOI: 10.1016/S1470-2045(24)00192-X2024
Journal article
Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand
DOI: 10.1111/ajo.13792
RECENT SCHOLARLY WORKS
2023
Journal article
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial
DOI: 10.1016/S1470-2045(23)00147-X2023
Journal article
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
DOI: 10.1038/s41416-023-02141-02022
Journal article
The changing role for extended resections in an era of advanced radiotherapy techniques and novel therapies in gynaecological malignancy
DOI: 10.1016/j.ejso.2022.09.0102022
Conference Proceedings
Staging locally advanced cervical cancer with FIGO 2018 versus FIGO 2008: Impact on overall survival and progression-free survival in the OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).
DOI: 10.1200/jco.2022.40.16_suppl.5531